Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Obesity | Research article

Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study

Authors: Ingvild Kristine Blom-Høgestøl, Martin Aasbrenn, Monica Chahal-Kummen, Cathrine Brunborg, Inger Eribe, Jon Kristinsson, Per G. Farup, Tom Mala

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Irritable bowel syndrome (IBS) is prevalent in patients with morbid obesity. After Roux-en-Y gastric bypass (RYGB) chronic abdominal pain is common, however the etiology is largely unknown. We aimed to study the change in the prevalence of IBS-like symptoms 2 years after RYGB and possible preoperative predictors of such symptoms. Secondly, to evaluate changes in symptoms of constipation and diarrhea, and Health related quality of life (HRQoL).

Methods

Patients with morbid obesity were included at two obesity centers in South-Eastern Norway. IBS was diagnosed according to the Rome III criteria. Predictors were evaluated in a multivariable logistic regression analysis.

Results

Of 307 participants operated with RYGB, 233 (76%) completed the study questionnaires. Preoperatively 27/233 participants (12%) had IBS, 2 years after RYGB 61/233 (26%) had IBS-like symptoms (p < 0.001). Eleven participants with IBS preoperatively (41%) did not report such symptoms after RYGB. New onset IBS-like symptoms was identified in 45/206 (22%) after RYGB. Fibromyalgia, low LDL levels, high vitamin B1 levels and IBS before RYGB were independent preoperative predictors of IBS-like symptoms at the follow-up visit. Symptom scores for constipation preoperatively and 2 year after RYGB were 1.5 (0.9) and 1.8 (1.2), and for diarrhea 1.4 (0.9) and 1.8 (1.1), respectively (p < 0.001). We observed a significant improvement in the physical component score for all participants. However, participants with new onset IBS-like symptoms had a significant worsening of the mental component score.

Conclusions

The prevalence of IBS-like symptoms doubled 2 years after RYGB, and these symptoms were associated with reduced HRQoL. Preoperative IBS and fibromyalgia were strong predictors of postoperative IBS-like symptoms.
Literature
1.
go back to reference Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075–1082. PubMed PMID: 26818616. Epub 2016/01/29. eng.CrossRef Sperber AD, Dumitrascu D, Fukudo S, Gerson C, Ghoshal UC, Gwee KA, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome Foundation working team literature review. Gut. 2017;66(6):1075–1082. PubMed PMID: 26818616. Epub 2016/01/29. eng.CrossRef
2.
go back to reference Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline JM. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg 2012;22(3):403–410. PubMed PMID: 21503810. Epub 2011/04/20. eng.CrossRef Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline JM. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg 2012;22(3):403–410. PubMed PMID: 21503810. Epub 2011/04/20. eng.CrossRef
3.
go back to reference Bouchoucha M, Fysekidis M, Julia C, Airinei G, Catheline JM, Reach G, et al. Functional gastrointestinal disorders in obese patients. The importance of the enrollment source. Obes Surg 2015;25(11):2143–2152. PubMed PMID: 25904236. Epub 2015/04/24. eng.CrossRef Bouchoucha M, Fysekidis M, Julia C, Airinei G, Catheline JM, Reach G, et al. Functional gastrointestinal disorders in obese patients. The importance of the enrollment source. Obes Surg 2015;25(11):2143–2152. PubMed PMID: 25904236. Epub 2015/04/24. eng.CrossRef
4.
go back to reference Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med 2017;376(26):2566–2578. PubMed PMID: 28657875. Epub 2017/06/29. eng.CrossRef Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med 2017;376(26):2566–2578. PubMed PMID: 28657875. Epub 2017/06/29. eng.CrossRef
5.
go back to reference Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491. PubMed PMID: 16678561. Epub 2006/05/09. eng.CrossRef Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491. PubMed PMID: 16678561. Epub 2006/05/09. eng.CrossRef
6.
go back to reference Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric surgery and Endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 2017;27(9):2279–2289. PubMed PMID: 28405878. Pubmed Central PMCID: PMC5562777. Epub 2017/04/14. eng.CrossRef Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric surgery and Endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 2017;27(9):2279–2289. PubMed PMID: 28405878. Pubmed Central PMCID: PMC5562777. Epub 2017/04/14. eng.CrossRef
7.
go back to reference Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA surgery 2018;153(5):427–434. PubMed PMID: 29214306. Epub 2017/12/08. eng.CrossRef Courcoulas AP, King WC, Belle SH, Berk P, Flum DR, Garcia L, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study. JAMA surgery 2018;153(5):427–434. PubMed PMID: 29214306. Epub 2017/12/08. eng.CrossRef
8.
go back to reference Suter M, Donadini A, Romy S, Demartines N, Giusti V. Laparoscopic roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 2011;254(2):267–273. PubMed PMID: 21772127. Epub 2011/07/21. eng.CrossRef Suter M, Donadini A, Romy S, Demartines N, Giusti V. Laparoscopic roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg 2011;254(2):267–273. PubMed PMID: 21772127. Epub 2011/07/21. eng.CrossRef
9.
go back to reference Risstad H, Sovik TT, Hewitt S, Kristinsson JA, Fagerland MW, Bernklev T, et al. Changes in health-related quality of life after gastric bypass in patients with and without obesity-related disease. Obes Surg 2015;25(12):2408–2416. PubMed PMID: 26003550. Epub 2015/05/25. eng.CrossRef Risstad H, Sovik TT, Hewitt S, Kristinsson JA, Fagerland MW, Bernklev T, et al. Changes in health-related quality of life after gastric bypass in patients with and without obesity-related disease. Obes Surg 2015;25(12):2408–2416. PubMed PMID: 26003550. Epub 2015/05/25. eng.CrossRef
10.
go back to reference Hogestol IK, Chahal-Kummen M, Eribe I, Brunborg C, Stubhaug A, Hewitt S, et al. Chronic abdominal pain and symptoms 5 years after gastric bypass for morbid obesity. Obes Surg 2017;27(6):1438–1445. PubMed PMID: 28028658. Epub 2016/12/29. eng.CrossRef Hogestol IK, Chahal-Kummen M, Eribe I, Brunborg C, Stubhaug A, Hewitt S, et al. Chronic abdominal pain and symptoms 5 years after gastric bypass for morbid obesity. Obes Surg 2017;27(6):1438–1445. PubMed PMID: 28028658. Epub 2016/12/29. eng.CrossRef
11.
go back to reference Gribsholt SB, Pedersen AM, Svensson E, Thomsen RW, Richelsen B. Prevalence of self-reported symptoms after gastric bypass surgery for obesity. JAMA surgery 2016;151(6):504–511. PubMed PMID: 26747510. Epub 2016/01/10. eng.CrossRef Gribsholt SB, Pedersen AM, Svensson E, Thomsen RW, Richelsen B. Prevalence of self-reported symptoms after gastric bypass surgery for obesity. JAMA surgery 2016;151(6):504–511. PubMed PMID: 26747510. Epub 2016/01/10. eng.CrossRef
12.
go back to reference Chahal-Kummen MIB-H, Eribe I, Klungsøyr O, Kristinsson J, Mala T. Abdominal pain and symptoms before and two years after roux-en-Y gastric bypass. BJS Open. 2019;3:317–26.CrossRef Chahal-Kummen MIB-H, Eribe I, Klungsøyr O, Kristinsson J, Mala T. Abdominal pain and symptoms before and two years after roux-en-Y gastric bypass. BJS Open. 2019;3:317–26.CrossRef
13.
go back to reference Pernar LI, Lockridge R, McCormack C, Chen J, Shikora SA, Spector D, et al. An effort to develop an algorithm to target abdominal CT scans for patients after gastric bypass. Obes Surg 2016;26(10):2543–2546. PubMed PMID: 27523471. Epub 2016/08/16. eng.CrossRef Pernar LI, Lockridge R, McCormack C, Chen J, Shikora SA, Spector D, et al. An effort to develop an algorithm to target abdominal CT scans for patients after gastric bypass. Obes Surg 2016;26(10):2543–2546. PubMed PMID: 27523471. Epub 2016/08/16. eng.CrossRef
14.
go back to reference Blom-Hogestol IK, Stubhaug A, Kristinsson JA, Mala T. Diagnosis and treatment of chronic abdominal pain 5 years after roux-en-Y gastric bypass. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2018;14(10):1544–1551. PubMed PMID: 30449511. Epub 2018/11/20. eng.CrossRef Blom-Hogestol IK, Stubhaug A, Kristinsson JA, Mala T. Diagnosis and treatment of chronic abdominal pain 5 years after roux-en-Y gastric bypass. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2018;14(10):1544–1551. PubMed PMID: 30449511. Epub 2018/11/20. eng.CrossRef
15.
go back to reference Pierik AS, Coblijn UK, de Raaff CAL, van Veen RN, van Tets WF, van Wagensveld BA. Unexplained abdominal pain in morbidly obese patients after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2017;13(10):1743–1751. PubMed PMID: 28728833. Epub 2017/07/22. eng.CrossRef Pierik AS, Coblijn UK, de Raaff CAL, van Veen RN, van Tets WF, van Wagensveld BA. Unexplained abdominal pain in morbidly obese patients after bariatric surgery. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2017;13(10):1743–1751. PubMed PMID: 28728833. Epub 2017/07/22. eng.CrossRef
16.
go back to reference Schauer PR, Ikramuddin S, Hamad G, Eid GM, Mattar S, Cottam D, et al. Laparoscopic gastric bypass surgery: current technique. Journal of laparoendoscopic & advanced surgical techniques Part A 2003;13(4):229–239. PubMed PMID: 14561251. Epub 2003/10/17. eng. Schauer PR, Ikramuddin S, Hamad G, Eid GM, Mattar S, Cottam D, et al. Laparoscopic gastric bypass surgery: current technique. Journal of laparoendoscopic & advanced surgical techniques Part A 2003;13(4):229–239. PubMed PMID: 14561251. Epub 2003/10/17. eng.
17.
go back to reference Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33(2):129–134. PubMed PMID: 3123181. Epub 1988/02/01. eng. Svedlund J, Sjodin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33(2):129–134. PubMed PMID: 3123181. Epub 1988/02/01. eng.
18.
go back to reference Karlsen TI, Tveita EK, Natvig GK, Tonstad S, Hjelmesaeth J. Validity of the SF-36 in patients with morbid obesity. Obes Facts 2011;4(5):346–351. PubMed PMID: 22166753. Epub 2011/12/15. eng.CrossRef Karlsen TI, Tveita EK, Natvig GK, Tonstad S, Hjelmesaeth J. Validity of the SF-36 in patients with morbid obesity. Obes Facts 2011;4(5):346–351. PubMed PMID: 22166753. Epub 2011/12/15. eng.CrossRef
19.
go back to reference Pickett-Blakely O. Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol 2014;10(7):411–416. PubMed PMID: 25904828. Pubmed Central PMCID: PMC4302488. Epub 2015/04/24. eng. Pickett-Blakely O. Obesity and irritable bowel syndrome: a comprehensive review. Gastroenterol Hepatol 2014;10(7):411–416. PubMed PMID: 25904828. Pubmed Central PMCID: PMC4302488. Epub 2015/04/24. eng.
20.
go back to reference Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006;51(3):454–460. PubMed PMID: 16614951. Epub 2006/04/15. eng.CrossRef Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006;51(3):454–460. PubMed PMID: 16614951. Epub 2006/04/15. eng.CrossRef
21.
go back to reference Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991;30(3):220–222. PubMed PMID: 2049586. Epub 1991/06/01. eng.CrossRef Veale D, Kavanagh G, Fielding JF, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991;30(3):220–222. PubMed PMID: 2049586. Epub 1991/06/01. eng.CrossRef
22.
go back to reference Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A, et al. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 2012;28(6):519–526. PubMed PMID: 22673485. Epub 2012/06/08. eng.CrossRef Chalaye P, Goffaux P, Bourgault P, Lafrenaye S, Devroede G, Watier A, et al. Comparing pain modulation and autonomic responses in fibromyalgia and irritable bowel syndrome patients. Clin J Pain 2012;28(6):519–526. PubMed PMID: 22673485. Epub 2012/06/08. eng.CrossRef
23.
go back to reference Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am J Med Sci 2009;338(2):116–119. PubMed PMID: 19561452. Epub 2009/06/30. eng.CrossRef Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A. Increased frequency of prediabetes in patients with irritable bowel syndrome. Am J Med Sci 2009;338(2):116–119. PubMed PMID: 19561452. Epub 2009/06/30. eng.CrossRef
24.
go back to reference Aasbrenn M, Hogestol I, Eribe I, Kristinsson J, Lydersen S, Mala T, et al. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study. BMC obesity 2017;4:22. PubMed PMID: 28680646. Pubmed Central PMCID: PMC5490229. Epub 2017/07/07. eng. Aasbrenn M, Hogestol I, Eribe I, Kristinsson J, Lydersen S, Mala T, et al. Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study. BMC obesity 2017;4:22. PubMed PMID: 28680646. Pubmed Central PMCID: PMC5490229. Epub 2017/07/07. eng.
25.
go back to reference Goldstone AP, Miras AD, Scholtz S, Jackson S, Neff KJ, Penicaud L, et al. Link between increased satiety gut hormones and reduced food reward after gastric bypass surgery for obesity. J Clin Endocrinol Metab 2016;101(2):599–609. PubMed PMID: 26580235. Pubmed Central PMCID: PMC4880130. Epub 2015/11/19. eng.CrossRef Goldstone AP, Miras AD, Scholtz S, Jackson S, Neff KJ, Penicaud L, et al. Link between increased satiety gut hormones and reduced food reward after gastric bypass surgery for obesity. J Clin Endocrinol Metab 2016;101(2):599–609. PubMed PMID: 26580235. Pubmed Central PMCID: PMC4880130. Epub 2015/11/19. eng.CrossRef
26.
go back to reference Zoon HFA, de Bruijn SEM, Smeets PAM, de Graaf C, Janssen IMC, Schijns W, et al. Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery. Behav Brain Res 2018;353:194–202. PubMed PMID: 30041007. Epub 2018/07/25. eng.CrossRef Zoon HFA, de Bruijn SEM, Smeets PAM, de Graaf C, Janssen IMC, Schijns W, et al. Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery. Behav Brain Res 2018;353:194–202. PubMed PMID: 30041007. Epub 2018/07/25. eng.CrossRef
27.
go back to reference Kvehaugen AS, Farup PG. Changes in gastrointestinal symptoms and food tolerance 6 months following weight loss surgery: associations with dietary changes, weight loss and the surgical procedure. BMC obesity 2018;5:29. PubMed PMID: 30524734. Pubmed Central PMCID: PMC6276242. Epub 2018/12/14. eng. Kvehaugen AS, Farup PG. Changes in gastrointestinal symptoms and food tolerance 6 months following weight loss surgery: associations with dietary changes, weight loss and the surgical procedure. BMC obesity 2018;5:29. PubMed PMID: 30524734. Pubmed Central PMCID: PMC6276242. Epub 2018/12/14. eng.
28.
go back to reference Sovik TT, Karlsson J, Aasheim ET, Fagerland MW, Bjorkman S, Engstrom M, et al. Gastrointestinal function and eating behavior after gastric bypass and duodenal switch. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2013;9(5):641–647. PubMed PMID: 22951078. Epub 2012/09/07. eng.CrossRef Sovik TT, Karlsson J, Aasheim ET, Fagerland MW, Bjorkman S, Engstrom M, et al. Gastrointestinal function and eating behavior after gastric bypass and duodenal switch. Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery. 2013;9(5):641–647. PubMed PMID: 22951078. Epub 2012/09/07. eng.CrossRef
29.
go back to reference Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic roux-en-Y gastric bypass. Obes Surg 2003;13(4):610–614. PubMed PMID: 12935364. Epub 2003/08/26. eng.CrossRef Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic roux-en-Y gastric bypass. Obes Surg 2003;13(4):610–614. PubMed PMID: 12935364. Epub 2003/08/26. eng.CrossRef
30.
go back to reference Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. Journal of managed care pharmacy: JMCP 2013;19(9):755–764. PubMed PMID: 24156644. Epub 2013/10/26. eng.CrossRef Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. Journal of managed care pharmacy: JMCP 2013;19(9):755–764. PubMed PMID: 24156644. Epub 2013/10/26. eng.CrossRef
31.
go back to reference Przekop P, Haviland MG, Zhao Y, Oda K, Morton KR, Fraser GE. Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents. The Journal of the American Osteopathic Association 2012;112(11):726–735. PubMed PMID: 23139343. Pubmed Central PMCID: PMC3542981. Epub 2012/11/10. eng. Przekop P, Haviland MG, Zhao Y, Oda K, Morton KR, Fraser GE. Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents. The Journal of the American Osteopathic Association 2012;112(11):726–735. PubMed PMID: 23139343. Pubmed Central PMCID: PMC3542981. Epub 2012/11/10. eng.
Metadata
Title
Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study
Authors
Ingvild Kristine Blom-Høgestøl
Martin Aasbrenn
Monica Chahal-Kummen
Cathrine Brunborg
Inger Eribe
Jon Kristinsson
Per G. Farup
Tom Mala
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1103-0

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.